Sign In
test

Sherman G. Souther

Venrock Adviser, Llc

Assets Managed
$2.679B
Holdings
33
Last Quarter
2026 - Q1
Filed Date
1mo ago
Growth Rate
32.34%(2Q avg: 23.15%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Venrock Adviser, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 33 positions.

Assets under management

The assets under management (AUM) of Venrock Adviser, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.679B in assets, with a quarterly growth rate of 32.34% and a 2-quarter average growth rate of 23.15%. The portfolio is managed by Sherman G. Souther, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
APGE
Apogee Therapeutics Inc
Recent Activity
26.69%
$714.883M
8.493M shares@ $84.18 avg price
ERAS
Erasca Inc
Recent Activity
Decreased -8.25%
9.9%
$265.074M
16.383M shares@ $16.18 avg price
ORKA
Oruka Therapeutics Inc
Recent Activity
7.6%
$203.48M
4.148M shares@ $49.05 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
6.94%
$185.894M
3.685M shares@ $50.44 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
Decreased -3.78%
4.87%
$130.331M
6.474M shares@ $20.13 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Increased 18%
3.7%
$99.026M
1.18M shares@ $83.92 avg price
GLTO
Galecto Inc
Recent Activity
New Position
3.49%
$93.333M
3.604M shares@ $25.91 avg price
OCUL
Ocular Therapeutix Inc
Recent Activity
Increased 41.44%
3.28%
$87.638M
10.347M shares@ $8.47 avg price
COGT
Cogent Biosciences Inc
Recent Activity
2.88%
$76.98M
2M shares@ $38.49 avg price
VRDN
Viridian Therapeutics Inc
Recent Activity
2.84%
$75.946M
3.883M shares@ $19.56 avg price

1-10 of 33